DAVITA INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
DAVITA INC. (DVA) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $1.05 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-02-11
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-12-31 was $249.43M, a 1.80% decline year-over-year.
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-09-30 was $319.75M, a 46.99% increase year-over-year.
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-06-30 was $351.03M, a 37.73% increase year-over-year.
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-03-31 was $291.55M, a 4.90% increase year-over-year.
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $1.05B, a 15.75% decline from fiscal 2024.
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $1.25B, a 30.70% increase from fiscal 2023.
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $956.98M, a 24.58% increase from fiscal 2022.
- DAVITA INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $768.19M, a 36.61% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.05B 10-K · filed 2026-02-11 | |||||||
| 2024-12-31 | $1.25B 10-K · filed 2026-02-11 | |||||||
| 2023-12-31 | $956.98M 10-K · filed 2026-02-11 | |||||||
| 2022-12-31 | $768.19M 10-K · filed 2025-02-13 | |||||||
| 2021-12-31 | $249.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $569.19M derived: sum of 2 quarters · filed 2024-02-14 | $920.22M derived: sum of 3 quarters · filed 2024-02-14 | $1.21B 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $319.75M 10-Q · filed 2021-10-28 | $670.78M derived: sum of 2 quarters · filed 2021-10-28 | $962.33M 10-Q · filed 2021-10-28 | $1.22B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $351.03M 10-Q · filed 2021-08-03 | $642.58M 10-Q · filed 2021-08-03 | $896.58M derived: sum of 3 quarters · filed 2023-02-22 | $1.11B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $291.55M 10-Q · filed 2021-04-29 | $545.55M derived: sum of 2 quarters · filed 2023-02-22 | $763.09M derived: sum of 3 quarters · filed 2023-02-22 | $1.02B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $254.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $471.54M derived: sum of 2 quarters · filed 2023-02-22 | $726.41M derived: sum of 3 quarters · filed 2023-02-22 | $1.00B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $217.54M 10-Q · filed 2021-10-28 | $472.41M derived: sum of 2 quarters · filed 2021-10-28 | $750.33M 10-Q · filed 2021-10-28 | $1.05B derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-06-30 | $254.87M 10-Q · filed 2021-08-03 | $532.79M 10-Q · filed 2021-08-03 | $833.12M derived: sum of 3 quarters · filed 2022-02-11 | $1.04B derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-03-31 | $277.92M 10-Q · filed 2021-04-29 | $578.25M derived: sum of 2 quarters · filed 2022-02-11 | $786.78M derived: sum of 3 quarters · filed 2022-02-11 | $1.03B derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2019-12-31 | $300.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $508.86M derived: sum of 2 quarters · filed 2022-02-11 | $756.63M derived: sum of 3 quarters · filed 2022-02-11 | $915.81M 10-K · filed 2022-02-11 | ||||
| 2019-09-30 | $208.53M 10-Q · filed 2020-10-29 | $456.30M derived: sum of 2 quarters · filed 2020-10-29 | $615.48M 10-Q · filed 2020-10-29 | $822.84M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $247.76M 10-Q · filed 2020-07-30 | $406.95M 10-Q · filed 2020-07-30 | $614.31M derived: sum of 3 quarters · filed 2021-02-12 | $729.38M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $159.18M 10-Q · filed 2020-05-05 | $366.55M derived: sum of 2 quarters · filed 2021-02-12 | $481.62M derived: sum of 3 quarters · filed 2021-02-12 | $718.25M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $207.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $322.44M derived: sum of 2 quarters · filed 2021-02-12 | $559.06M derived: sum of 3 quarters · filed 2021-02-12 | $790.08M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $115.07M 10-Q · filed 2019-11-07 | $351.70M derived: sum of 2 quarters · filed 2019-11-07 | $582.71M 10-Q · filed 2019-11-07 | $779.80M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $236.63M 10-Q · filed 2019-08-02 | $467.64M 10-Q · filed 2019-08-02 | $664.73M derived: sum of 3 quarters · filed 2020-02-21 | $863.57M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $231.01M 10-Q · filed 2019-05-07 | $428.11M derived: sum of 2 quarters · filed 2020-02-21 | $626.95M derived: sum of 3 quarters · filed 2020-02-21 | $813.09M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $197.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $395.93M derived: sum of 2 quarters · filed 2020-02-21 | $582.08M derived: sum of 3 quarters · filed 2020-02-21 | $1.08B 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | $198.84M 10-Q · filed 2018-11-07 | $384.98M derived: sum of 2 quarters · filed 2018-11-07 | $878.84M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $186.15M 10-Q · filed 2018-08-01 | $680.00M 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | $493.85M 10-Q · filed 2018-05-03 | |||||||
| 2016-12-31 | $1.19B 10-K · filed 2019-02-22 | |||||||
| 2015-12-31 | $480.88M 10-K · filed 2018-02-23 | $427.41M 10-K · filed 2016-02-26 | ||||||
| 2014-12-31 | $250.39M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $470.17M derived: sum of 2 quarters · filed 2016-02-26 | $651.59M derived: sum of 3 quarters · filed 2016-02-26 | $863.33M 10-K · filed 2016-02-26 | ||||
| 2014-09-30 | $219.78M 10-Q · filed 2014-11-06 | $401.20M derived: sum of 2 quarters · filed 2014-11-06 | $612.94M 10-Q · filed 2014-11-06 | $857.22M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $181.42M 10-Q · filed 2014-08-01 | $393.16M 10-Q · filed 2014-08-01 | $637.43M derived: sum of 3 quarters · filed 2016-02-26 | $807.27M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $211.74M 10-Q · filed 2014-05-02 | $456.01M derived: sum of 2 quarters · filed 2016-02-26 | $625.85M derived: sum of 3 quarters · filed 2016-02-26 | $909.20M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $244.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $414.11M derived: sum of 2 quarters · filed 2016-02-26 | $697.47M derived: sum of 3 quarters · filed 2016-02-26 | $743.97M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $169.84M 10-Q · filed 2014-11-06 | $453.19M derived: sum of 2 quarters · filed 2014-11-06 | $499.69M 10-Q · filed 2014-11-06 | $683.95M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $283.36M 10-Q · filed 2014-08-01 | $329.86M 10-Q · filed 2014-08-01 | $514.12M derived: sum of 3 quarters · filed 2015-02-26 | $686.68M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $46.50M 10-Q · filed 2014-05-02 | $230.76M derived: sum of 2 quarters · filed 2015-02-26 | $403.32M derived: sum of 3 quarters · filed 2015-02-26 | $522.97M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $184.26M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $356.82M derived: sum of 2 quarters · filed 2015-02-26 | $476.48M derived: sum of 3 quarters · filed 2015-02-26 | $641.46M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $172.56M 10-Q · filed 2013-11-06 | $172.55M 10-Q · filed 2012-10-31 | $292.21M derived: sum of 2 quarters · filed 2013-11-06 | $457.20M 10-Q · filed 2013-11-06 | $457.44M 10-Q · filed 2012-10-31 | $649.02M derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-06-30 | $119.65M 10-Q · filed 2013-08-07 | $120.00M 10-Q · filed 2012-08-03 | $284.64M 10-Q · filed 2013-08-07 | $284.89M 10-Q · filed 2012-08-03 | $476.46M derived: sum of 3 quarters · filed 2014-02-21 | $640.92M derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-03-31 | $164.98M 10-Q · filed 2013-05-09 | $164.88M 10-Q · filed 2012-05-02 | $356.81M derived: sum of 2 quarters · filed 2014-02-21 | $521.26M derived: sum of 3 quarters · filed 2014-02-21 | $641.68M derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2011-12-31 | $191.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $356.28M derived: sum of 2 quarters · filed 2014-02-21 | $476.69M derived: sum of 3 quarters · filed 2014-02-21 | $591.31M 10-K · filed 2014-02-21 | $576.93M 10-K · filed 2012-02-24 | |||
| 2011-09-30 | $164.46M 10-Q · filed 2012-10-31 | $284.87M derived: sum of 2 quarters · filed 2012-10-31 | $399.49M 10-Q · filed 2012-10-31 | $490.27M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $120.41M 10-Q · filed 2012-08-03 | $235.03M 10-Q · filed 2012-08-03 | $325.81M derived: sum of 3 quarters · filed 2013-03-01 | $468.79M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $114.62M 10-Q · filed 2012-05-02 | $205.40M derived: sum of 2 quarters · filed 2013-03-01 | $348.38M derived: sum of 3 quarters · filed 2013-03-01 | |||||
| 2010-12-31 | $90.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $233.75M derived: sum of 2 quarters · filed 2013-03-01 | $482.36M 10-K · filed 2013-03-01 | $483.94M 10-K · filed 2012-02-24 | ||||
| 2010-09-30 | $142.98M 10-Q · filed 2011-11-04 | $391.59M 10-Q · filed 2011-11-04 | ||||||
| 2009-12-31 | $479.37M 8-K · filed 2012-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |